Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 33.31M 38.11M 30.81M 28.27M 53.51M 3.67B 54.43M 367M 144M 1.79B 143M 140M 6.19B | P/E 2026 * |
-5.4x | P/E 2027 * | 37.8x |
|---|---|---|---|---|---|
| Enterprise Value | 33.31M 38.11M 30.81M 28.27M 53.51M 3.67B 54.43M 367M 144M 1.79B 143M 140M 6.19B | EV / Sales 2026 * |
11.1x | EV / Sales 2027 * | 3.33x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 2024-02-27 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 2014-12-31 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 2024-04-07 |
Damian Marron
CHM | Chairman | 64 | 2024-07-15 |
Marc Bozec
BRD | Director/Board Member | - | 2024-07-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 38.51M | |
| +3.25% | +2.05% | +54.83% | +18.90% | 305B | |
| -1.53% | -1.18% | +24.90% | -7.73% | 69.67B | |
| +2.27% | -1.37% | +33.67% | +102.88% | 8.99B | |
| +1.17% | +1.34% | +5.54% | +0.13% | 8.52B | |
| -3.05% | +0.42% | +6.92% | +28.13% | 4.17B | |
| +1.53% | -1.00% | -18.56% | +3.79% | 4.11B | |
| +1.87% | +5.04% | -37.18% | +24.94% | 3.48B | |
| +1.01% | -1.11% | +43.82% | +60.54% | 2.77B | |
| -0.81% | +7.81% | +12.16% | -16.29% | 2.28B | |
| Average | -0.22% | -0.82% | +14.01% | +23.92% | 45.48B | |
| Weighted average by Cap. | +2.24% | -1.76% | +45.93% | +15.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.43M 2.77M 2.55M 4.82M 331M 4.9M 33.09M 13M 161M 12.89M 12.61M 558M | 10M 11.44M 9.25M 8.49M 16.06M 1.1B 16.34M 110M 43.33M 538M 42.96M 42.02M 1.86B |
| Net income | -6M -6.86M -5.55M -5.09M -9.64M -661M -9.8M -66.17M -26M -323M -25.78M -25.21M -1.12B | 1M 1.14M 925K 849K 1.61M 110M 1.63M 11.03M 4.33M 53.83M 4.3M 4.2M 186M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Choose MarketScreener 
